Diagnosis and Management of Non-Metastatic Upper Tract Urothelial Carcinoma: AUA/SUO Guideline

原文： 2023 年发布于 J Urol 209 卷第 6 期 45-49  浏览量：218次

作者： Coleman J. A. Clark P. E. Bixler B. R. Buckley D. I. Chang S. S. Chou R. Hoffman-Censits J. Kulkarni G. S. Matin S. F. Pierorazio P. M. Potretzke A. M. Psutka S. P. Raman J. D. Smith A. B. Smith L.

归属分类：膀胱肿瘤临床实践指南

DOI： 10.1159/000449256

文献简介

暂无

[Ⅱ. Update on Guideline for Management of Metastatic Urothelial Carcinoma]

窄带成像在非肌层浸润性膀胱癌诊治中的应用安全共识(2020版)

热门文献

GSTM1 and GSTT1 polymorphisms are associated with increased bladder cancer risk: Evidence from updated meta-analysis

 Clin Invest Med 1108
Efficacy and toxicity in scheduled intravesical gemcitabine versus Bacille Calmette-Guerin for Ta and T1 bladder cancer: a systematic review and meta-analysis

 J Cancer Res Ther 39 卷第 6 期 832
吉西他滨较丝裂霉素治疗 TURBT 后非肌层浸润性膀胱癌的复发率低、毒副作用小 : 基于随机对照试验的荟萃分析

 PeerJ 60 卷第 5 期 776
Clinicopathological and Prognostic Value of Ki-67 Expression in Bladder Cancer: A Systematic Review and Meta-Analysis

 Bmc Urology 707
Urinary human papilloma virus infection and bladder cancer risk: A systematic review and a prisma-compliant meta-analysis

 Int J Nurs Pract 13 卷第 4 期 706
膀胱癌标本规范化处理和病理诊断共识

 中华病理学杂志 49卷第4期 665
Meta-analysis of a 10-plex urine-based biomarker assay for the detection of bladder cancer

 Eur J Nutr 11 卷第 2 期 657
Clinical Outcomes after Intravesical Bacillus Calmette–Guérin for the Highest-risk Non-muscle-invasive Bladder Cancer Newly Defined in the Japanese Urological Association Guidelines 2019

 International Journal of Urology 656
Comparison of the prognosis of primary and progressive muscle-invasive bladder cancer after radical cystectomy: A systematic review and meta-analysis

 Oncotarget 651
[Adjuvant radiotherapy after radical cystectomy for muscle-invasive bladder cancer]

 Front Endocrinol (Lausanne) 13 卷第 11 期 631

Diagnosis and Management of Non-Metastatic Upper Tract Urothelial Carcinoma: AUA/SUO Guideline

原文： 2023 年发布于 J Urol 209 卷第 6 期 45-49  浏览量：218次

文献简介

上一篇

[Ⅱ. Update on Guideline for Management of Metastatic Urothelial Carcinoma]

下一篇

窄带成像在非肌层浸润性膀胱癌诊治中的应用安全共识(2020版)

GSTM1 and GSTT1 polymorphisms are associated with increased bladder cancer risk: Evidence from updated meta-analysis

Efficacy and toxicity in scheduled intravesical gemcitabine versus Bacille Calmette-Guerin for Ta and T1 bladder cancer: a systematic review and meta-analysis

吉西他滨较丝裂霉素治疗 TURBT 后非肌层浸润性膀胱癌的复发率低、毒副作用小 : 基于随机对照试验的荟萃分析

Clinicopathological and Prognostic Value of Ki-67 Expression in Bladder Cancer: A Systematic Review and Meta-Analysis

Urinary human papilloma virus infection and bladder cancer risk: A systematic review and a prisma-compliant meta-analysis

膀胱癌标本规范化处理和病理诊断共识

Meta-analysis of a 10-plex urine-based biomarker assay for the detection of bladder cancer

Clinical Outcomes after Intravesical Bacillus Calmette–Guérin for the Highest-risk Non-muscle-invasive Bladder Cancer Newly Defined in the Japanese Urological Association Guidelines 2019

Comparison of the prognosis of primary and progressive muscle-invasive bladder cancer after radical cystectomy: A systematic review and meta-analysis

[Adjuvant radiotherapy after radical cystectomy for muscle-invasive bladder cancer]

Diagnosis and Management of Non-Metastatic Upper Tract Urothelial Carcinoma: AUA/SUO Guideline

原文： 2023 年 发布于 J Urol 209 卷 第 6 期 45-49  浏览量：218次

文献简介

上一篇

下一篇

原文： 2023 年发布于 J Urol 209 卷第 6 期 45-49  浏览量：218次